18 November 2020

The list of the 1 percent most cited scientists of the past ten years contains seventeen scientists who are affiliated with Radboudumc or Radboud University. The list was published by Clarivate Analytics, an American company that offers services in the area of scientific research (e.g. Web of Science).

The annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.

Ten of seventeen researchers in the list of Highly Cited Researchers 2020 are classified in the ‘Cross-Field’ category, meaning they have been cited in different fields. Clarivate Analytics wants to use this category to break down the “artificial walls of conventional disciplinary categories”.

Mihai Netea, professor in Experimental Internal Medicine, is classified as a Highly Cited researcher in two fields: Microbiology as well as Immunology.

The seventeen Radboud scientists on the list are:

(*) Charles Dinarello is first and foremost affiliated with the University of Colorado Denver; Radboud Medical Center is his second affiliation. Pascal Fries is first and foremost affiliated with the Ernst Strüngmann Institute (ESI) for Neuroscience in cooperation with Max Planck Society; Radboud University is his second affiliation. Jacques Meis is first and foremost affiliated with the Canisius-Wilhelmina Hospital Nijmegen; Radboud University is his second affiliation.

Almost half of the scientists that are highly cited in their colleagues’ research are American (41.5 percent). The Netherlands is in seventh place, with 181 scientists.

 

Related news items


Radboud Young Academy safeguards the future of science

21 January 2021

New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.

read more

Increase radio- and immunotherapy efficacy by targeting hypoxia

21 January 2021

In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.

read more

Radiation boost lowers risk of prostate cancer recurrence

21 January 2021

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.

read more

New research through grants for Radboudumc researchers

14 January 2021

Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.

read more

Should we prepare for a corona-related depression wave? Indira Tendolkar and Eric Ruhé talk about their research projects

13 January 2021

Since the outbreak of the SARS-CoV-2, many of us have been staying at home in order to limit our social interactions, to keep ourselves and others safe from the virus. Yet, there’s also concern about what social distancing and anxiety generated by media reports are doing to people's mental health.

read more

RIMLS online award ceremony proudly presenting the winners

13 January 2021

In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony. 

read more